Status:
UNKNOWN
Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation in Colorectal Liver Metastases
Lead Sponsor:
Heidelberg University
Conditions:
Colorectal Liver Metastases
Eligibility:
All Genders
50-90 years
Phase:
PHASE1
PHASE2
Brief Summary
The efficiency of T cell based immunotherapies is affected by the insufficient migration and activity of tumor specific effector T cells in the tumor. Aim of this phase I/II clinical trial is to evalu...
Eligibility Criteria
Inclusion
- Ability of subject to understand character and individual consequences of the clinical trial
- Written informed consent (must be available before enrolment in the trial)
- Age ≥ 50 years
- Radiological urgently suspected colorectal liver metastasis
Exclusion
- second malignancy
- Pregnancy and lactation
- no prior liver radiation
- liver metastasis must be resectable
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01191632
Start Date
March 1 2010
End Date
March 1 2012
Last Update
October 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Heidelberg
Heidelberg, Germany, 69120